Intravitreal triamcinolone acetonide for the management of diabetic papillopathy

被引：32

作者：

Al-Haddad, CE ^{[1
]}

Jurdi, FA ^{[1
]}

Bashshur, ZF ^{[1
]}

机构：

[1] Amer Univ Beirut, Med Ctr, Dept Ophthalmol, Beirut, Lebanon

来源：

AMERICAN JOURNAL OF OPHTHALMOLOGY | 2004年 / 137卷 / 06期

关键词：

D O I：

10.1016/j.ajo.2004.01.032

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

PURPOSE: To present a case of severe drop in vision in both eyes caused by diabetic papillopathy that was treated with an intravitreal injection of triamcinolone acetonide. DESIGN: Interventional case report. METHODS: A diabetic patient with bilateral diabetic papa illopathy and drop in vision received sequential intravit, real triamcinolone acetonide injections to both eyes. RESULTS: Within 2 weeks of intravitreal injection, vision improved from counting fingers at 1 m to 20/50 OS, and from counting fingers at 4 m to 20/40 OD. This improve. ment was accompanied by resolution of disk swelling and macular edema. Vision remained stable in both eyes at 20/40 for 8 months of follow-up. No elevation of intraocular pressure beyond 21 mm Hg was noted at any time. CONCLUSION: Diabetic papillopathy with severe drop in vision can be treated with intravitreal triamcinolone acetonide injection. @ 2004 by Elsevier Inc. All rights reserved.

引用

页码：1151 / 1153

页数：3